|
|
|
Event Videos
|
https://pubmed.ncbi.nlm.nih.gov/33919162/ hepatoblastoma Cancers (Basel). 2021 Apr 21;13(9):1996. Reconciling the Biological and Transcriptional Variability of Hepatoblastoma with Its Mutational Uniformity Abstract Published on:
Apr-2021
|
https://pubmed.ncbi.nlm.nih.gov/33907148/ Transient infantile hypertriglyceridemia with jaundice: A case report Jun Wang 1, Fang Sun 2, Pengfei Xu 1, Yufeng Zhang 1, Xinrong Sun 1, Huiling Deng 1 3 Abstract Published on:
Apr-2021
|
|
https://pubmed.ncbi.nlm.nih.gov/33921259/ hepatitis b Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia Sheikh Mohammad Fazle Akbar 1, Mamun Al Mahtab 2, Ferdousi Begum 3, Shaikh A Shahed Hossain 4, Sukumar Sarker 5, Ananta Shrestha 6, Md Sakirul Islam Khan 7, Osamu Yoshida 1, Yoichi Hiasa 1 Abstract Published on:
Apr-2021
|
https://pubmed.ncbi.nlm.nih.gov/33894100/ NAFLD Liver Int. 2021 Apr 24. Diagnostic accuracy of fibrosis tests in children with Non-Alcoholic Fatty Liver Disease (NAFLD): a systematic review Laura G Draijer 1 2 3, Janneke P M van Oosterhout 1, Yasaman Vali 4, Sabrina Zwetsloot 1, Johanna H van der Lee 5, Faridi S van Etten-Jamaludin 6, Malika Chegary 7, Marc A Benninga 1, Bart G P Koot 1 Abstract Published on:
Apr-2021
|
|
https://pubmed.ncbi.nlm.nih.gov/33926811/ Hepatic hydrothorax in a child and its management L Morin 1, S Branchereau 2, D Habes 3, S Franchi-Abella 4, E Gonzales 3 Abstract Published on:
Apr-2021
|
https://pubmed.ncbi.nlm.nih.gov/33871081/ NAFLD J Gastroenterol Hepatol. 2021 Apr 19. Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population Grazia Pennisi 1, Vito Di Marco 1, Carola Buscemi 1, Giovanni Mazzola 2, Cristiana Randazzo 3, Federica Spatola 1, Antonio Craxì 1, Silvio Buscemi 3, Salvatore Petta 1 Abstract Background and aims: Nonalcoholic fatty liver (NAFLD) is a major cause of liver disease worldwide leading also to a higher risk of cardiovascular events. We aimed to evaluate the impact of fatty liver and fibrosis on cardiovascular risk in a general population. Published on:
Apr-2021
|
|
https://pubmed.ncbi.nlm.nih.gov/33908738/ Wilson disease Fatty Acid-Binding Protein 1 as a Potential New Serological Marker of Liver Status in Children with Wilson Disease Joanna Beata Bierła 1, Wojciech Jańczyk, Ewa Konopka, Aldona Wierzbicka-Rucińska, Sebastian Więckowski, Łukasz Obrycki, Jędrzej Sarnecki, Ewelina Kanarek, Bożena Cukrowska, Piotr Socha Abstract Published on:
Apr-2021
|
https://pubmed.ncbi.nlm.nih.gov/33867627/ Med J Armed Forces India. 2021 Apr;77(2):129-137. Advances in management of end stage liver disease in children Aradhana Aneja 1, Elizabeth Scott 2, Rohit Kohli 3 Abstract Published on:
Apr-2021
|
|
https://pubmed.ncbi.nlm.nih.gov/33908737/ liver transplantation J Pediatr Gastroenterol Nutr. 2021 Mar 17. Current Evidence on the Clinical Relevance of Donor-Specific Antibodies in Paediatric Liver Transplantation Juliane K Götz 1, Hella Kiene, Imeke Goldschmidt, Norman Junge, Eva-Doreen Pfister, Christoph Leiskau, Rachel M Brown, Stephan Immenschuh, Ulrich Baumann Abstract Published on:
Apr-2021
|
https://pubmed.ncbi.nlm.nih.gov/33862225/ NAFLD Clin Gastroenterol Hepatol. 2021 Apr 13;S1542-3565(21)00448-1. Maternal and perinatal risk factors for pediatric non-alcoholic fatty liver disease: A systematic review Ilya Querter 1, Nele S Pauwels 2, Ruth De Bruyne 3, Ellen Dupont 4, Xavier Verhelst 1, Lindsey Devisscher 5, Hans Van Vlierberghe 1, Anja Geerts 1, Sander Lefere 6 Abstract Published on:
Apr-2021
|
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
